Access to Medicines and Vaccines
This open access book is the outcome of a Global Forum on Innovation, Intellectual Property and Access to Medicines held in December 2019 at the Max Plank Instititute in Munich, organised by the South Centre and the Max Plank Institute. The academics and
core +1 more source
A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries [PDF]
Background: Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as ...
Childs, Michelle +11 more
core +1 more source
Driving a decade of change: HIV/AIDS, patents and access to medicines for all [PDF]
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries.
Moon, Suerie +11 more
core +1 more source
Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors’ Participation, and Context [PDF]
Background Implementing medicines pricing policy effectively is important for ensuring equitable access to essential medicines and ultimately achieving universal health coverage. However, published analyses of policy implementations are scarce from low-
Augustina Koduah +7 more
doaj +1 more source
TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? [PDF]
BACKGROUND: The World Trade Organisation's Declaration on the TRIPS Agreement and Public Health (known as the Doha Declaration) of 2001, and subsequent Decision on the Interpretation of Paragraph 6 reached in 2003, affirmed the flexibilities available ...
Kerry Vanessa +5 more
core +1 more source
Towards a Patent Pool for HIV Medicines: The Background [PDF]
Recent WHO guidelines for antiretroviral therapy recommend switching to less toxic, but more expensive medicines for first-line and second-line ART, raising questions about the financial sustainability of many AIDS treatment programmes. At the same time,
Childs, Michelle
core +1 more source
COVID-19, IP and access: Will the current system of medical innovation and access to medicines meet global expectations? [PDF]
Copyright © The Author(s) 2021. The COVID-19 pandemic has exposed the fundamental flaws in the current system of medical innovation and access to medicines, which require urgent attention from the global community.
Gurgula, O, Lee, WH
core +1 more source
Embracing context: Lessons from designing a dialogue-based intervention to address vaccine hesitancy
Dialogue with people who are vaccine hesitant has been recommended as a method to increase vaccination uptake. The process of cultivating dialogue is shaped by the context in which it occurs, yet the development of interventions addressing vaccine ...
ToTran Nguyen +12 more
doaj +1 more source
Access to Medicines, Access to Markets
This article explores some uses by the pharmaceutical industry of language from the “access to medicines” movement in global health, sometimes for goals almost completely opposite to those of the movement.
Sergio Sismondo
doaj +1 more source
Ensuring Global Access to Cancer Medicines: A Generational Call to Action [PDF]
Essential cancer treatments are not accessible, affordable, or available to patients who need them in many parts of the world. A new Access to Oncology Medicines (ATOM) Coalition, using public–private partnerships, aims to bring essential cancer ...
Melissa Siaw Han, Lim +29 more
core +1 more source

